Adaptive Platform Trial to Investigate VArious ThErapies in Carotid-Associated Stroke (ACTIVATE-CAS)- Pilot Phase Carotid disease accounts for 10% of ischemic strokes and has high rate of recurrence of up to 30%-50%(1, 2). Grant type Team grants Area of Research Injury Competition Canadian Stroke Consortium-Brain Canada-Heart and Stroke Foundation of Canada 2022 Stroke Clinical Research Catalyst Grants Province Manitoba Start Date 2022
